Tech Transfer eNews Blog
Industry-Sponsored Research Management sample issue

Mayo Clinic links with start-up to develop thin film brain implant that can treat seizures and tremors

By Jesse Schwartz
Published: August 9th, 2017

The Mayo Clinic is collaborating with medtech startup NeuroOne to develop an implantable device to treat epilepsy, Parkinson’s disease and other brain disorders.

The start-up’s technology uses a novel “thin film” of electrodes developed at the University of Wisconsin. Through a minimally invasive procedure, the material is placed in the brain, where it combines ultra-sensitive detection capabilities with treatment options including deep brain stimulation (DBS) and ablation procedures to single out even the smallest levels of irregular brain activity as it would occur before a seizure or tremor.

While there are other related treatments available to patients with epilepsy and Parkinson’s, NueroOne’s product is unique in its small size, which only requires a dime-sized hole in the skull as opposed to a full craniotomy, as well as its heightened sensitivity, which allows it to detect single neuron brain activity for more rapid detection.

In March, NeuroOne completed a $1.2 million seed financing round with early stage healthcare venture capital firm FundRx, and later in the year the start-up’s founders converted their shares to publicly traded OSOK stock.

In exchange for the Mayo Clinic’s commitment to assist with the technology’s commercialization, it gets an 11% ownership stake in NeuroOne, as well as a royalty equal to a single-digit percentage of the sales of NeuroOne’s device.

Source: Twin Cities Business

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment